undamentalytics Newsletter
Sign in

Caredx, Inc. cash flow statement

In fiscal 2025, Caredx, Inc.'s operations generated $42.0m of cash; it spent $0 on capital projects, leaving free cash flow of $42.0m. It returned $87.8m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations−2−1−3−10−17−14−4−333−19−25−18384269
Depreciation and amortisation11113446791214141518
Stock-based pay00112272223364749663538
Capital spending001110200000000
Free cash flow−2−1−4−11−17−14−6−333−19−25−18384269
Free cash flow after stock pay−2−1−5−12−19−16−13−2510−55−72−67−28731
Share buybacks————————00128188—
Shares issued—————————18900———

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CDNA vs STLNCDNA vs USPHCDNA vs VMD

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Caredx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Caredx, Inc.